Project Grant K23GM159013
Award Date
6/1/25
Completion Date
5/31/28
Dollars Obligated
$179K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This $186,221 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop personalized sepsis therapies for pediatric patients. The key objectives are to: Enhance sepsis phenotyping by integrating high-frequency physiologic data with electronic health records to identify additional subtypes and predict disease progression. Retrospectively develop and externally validate...
This $455,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the "Suspect Treat Organ Failure Prevent Sepsis Mortality (STOP Sepsis Mortality)" project at the Children's Research Institute in Washington, D.C. The project aims to decrease pediatric sepsis mortality through three key activities: 1) developing an AI-guided early sepsis identification tool, 2) performing sepsis...
This National Institute of General Medical Sciences (NIGMS) Project Grant award under CFDA 93.859 (Biomedical Research and Research Training) supports research to investigate the role of T cell receptor (TCR) activation in neonatal and pediatric sepsis. The $418,750 award, effective from January 1, 2025 to November 30, 2029, will be conducted by the Feinstein Institutes for Medical Research, a leading non-profit research organization. The research aims to understand how T cell memory responses...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $721,728 to the Regents of the University of Michigan to conduct research on the modulation of pediatric sepsis by virus persistence. The research aims to investigate how persistent viral infections, even in the absence of reactivation, can affect clinical outcomes and response to immunomodulatory therapies in...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1,203,750 in funding to Cincinnati Children's Hospital Medical Center to conduct research on unraveling organ-specific microvascular endothelial responses in sepsis. The 5-year project aims to develop a transcriptomic atlas of circulating endothelial cells from children with septic shock, create human induced pluripotent stem...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to improve sepsis care through the development of artificial intelligence (AI) and machine learning (ML) based clinical decision support (CDS) systems. The $1,218,750 award to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, will support research to address key...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $658,426 to The Children's Hospital of Philadelphia (CHOP) over a 5-year period from Dec 2024 to Nov 2029. The grant supports research to investigate the mechanisms by which chronic STAT3 signaling, a rare genetic condition, leads to impaired CD8 T cell function and increased susceptibility to both viral...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $2,583,391.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research on sepsis pathogenesis and treatment. The key objectives are to: Identify known and novel pathogens responsible for septic shock using metagenomic sequencing of host and microbe samples. Discover novel sepsis...
This $1,147,992 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to advance precision medicine for acute respiratory distress syndrome (ARDS) and sepsis. The award aims to address key unanswered questions about the functional immune response and pathogen drivers underlying distinct "hyperinflammatory" and "hypoinflammatory" phenotypes observed in these critical...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $195,607 in funding to The Washington University in St. Louis to investigate the role of the ADAM10 protein in the dysregulated host response to pathogens that leads to sepsis. The primary goals are to: 1) Understand the molecular mechanisms by which diverse pathogens activate endothelial ADAM10, 2) Characterize...